Hutton J, Borowitz M, Oleksy I, Luce B R
Health Aff (Millwood). 1994 Summer;13(3):98-111. doi: 10.1377/hlthaff.13.3.98.
Many countries in Europe, which have significant pharmaceutical industries, recently have embarked on reforms in the organization of their health care systems and methods of regulating the pharmaceutical market. This paper describes the different systems in major European countries and the changes taking place. Although it is too early to make final judgment on the impact of these changes, it is possible to predict some of the more likely outcomes. The organizational models and regulatory approaches in Europe offer a useful store of experience for those assessing the potential impact of reform proposals in the United States.
欧洲许多拥有大型制药产业的国家，最近已着手对其医疗保健系统的组织架构和药品市场监管方法进行改革。本文描述了欧洲主要国家的不同体系以及正在发生的变化。尽管现在对这些变化的影响做出最终判断还为时过早，但预测一些较有可能出现的结果是可行的。欧洲的组织模式和监管方法为那些评估美国改革提案潜在影响的人人人提供了宝贵的经验储备。
